What Clinical Strategies Are Applied for Botulinum Toxin Injection in the Oromandibular Region?
| Autor: | Eigild Møller, Merete Bakke, Torben Dalager |
|---|---|
| Přispěvatelé: | Rosales, R, Dressler, D |
| Jazyk: | angličtina |
| Rok vydání: | 2016 |
| Předmět: | |
| Zdroj: | Bakke, M, Dalager, T & Møller, E 2016, What Clinical Strategies Are Applied for Botulinum Toxin Injection in the Oromandibular Region? in R Rosales & D Dressler (eds), Botulinum Toxin Therapy Manual for Dystonia and Spasticity . InTechOpen, Rijeka, pp. 79-95 . https://doi.org/10.5772/64271 Botulinum Toxin Therapy Manual for Dystonia and Spasticity |
| DOI: | 10.5772/64271 |
| Popis: | Botulinum neurotoxin (BoNT) inhibits the release of acetylcholine from cholinergic nerve terminals in muscles or salivary glands. With reduced activation, the muscle activity or secretion decreases. Indications for medical, non‐cosmetic use of BoNT in the orofacial area include among others oromandibular dystonia, painful masseter hypertrophy, Frey's syndrome, and severe drooling. The chapter covers anamnestic characteristics of these conditions as well as clinical, electromyographic (EMG) and laboratory findings, treatment methods with guided injections, and outcome from systematic treatment controls and follow‐up examinations. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|